Dr. Conor O'Toole:

Building a pharma plant is a 25- or 30-year investment of very large sums of capital. That will go past Trump's term in office and it will go to where things go next. Firms will try to make the best decision they can in an extremely uncertain environment, but we can certainly see it dampening investment already.